In conversation with... Elise Meima-van Praag

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.

Episode metadata supplied by the publisher feed · Published Jun 15, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Elise Meima-van Praag

0:00 9:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 9 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on June 15, 2022.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!